Claudius U. Meyer

Obere Zahlbacher Str. 63
Mainz, RP 55131, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations.

Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations.

Journal: International journal of biological macromolecules

Published: May 26, 2025

Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical Trial.

Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical Trial.

Journal: JAMA pediatrics

Published: August 05, 2024

Meconium Microbiome of Very Preterm Infants across Germany.

Meconium Microbiome of Very Preterm Infants across Germany.

Journal: mSphere

Published: January 12, 2022

Principles in Immunology for the Design and Development of Vaccines.

Principles in Immunology for the Design and Development of Vaccines.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 16, 2021

Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2.

Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2.

Journal: Frontiers in immunology

Published: October 22, 2021

Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocol.

Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocol.

Journal: BMJ open

Published: November 23, 2019

Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis.

Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis.

Journal: Pediatric research

Published: October 19, 2018

Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.

Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: August 12, 2016

Inflammatory Characteristics of Monocytes from Pediatric Patients with Tuberous Sclerosis.

Inflammatory Characteristics of Monocytes from Pediatric Patients with Tuberous Sclerosis.

Journal: Neuropediatrics

Published: September 11, 2015

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

Journal: Vaccine

Published: September 24, 2014

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.

Journal: Vaccine

Published: July 10, 2014

Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules.

Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules.

Journal: Biomacromolecules

Published: June 06, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026